NLM Digital Collections

Search

Start Over Subjects Health Expenditures -- trends ✖Remove constraint Subjects: Health Expenditures -- trends Genre Technical Report ✖Remove constraint Genre: Technical Report

42. Top spenders among commercially-insured: increased spending concentration and consistent turnover from 2013 to 2015

Author(s):
Johnson, Bill, author
Rodriguez, Sally, author
Publication:
Washington, DC : Health Care Cost Institute, February 2018
Subject(s):
Financing, Personal
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Drug Costs
Forecasting
Insurance, Health -- economics
Insurance, Pharmaceutical Services -- economics
Private Sector
Humans
United States

43. Under pressure: adults with hypertension are spending increasingly more on health care

Author(s):
Johnson, Bill, author
Fulop, Dan, author
Rodriguez, Sally, author
Publication:
Washington, DC : Health Care Cost Institute, March 2018
Subject(s):
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Hypertension -- economics
Hypertension -- therapy
Adult
Ambulatory Care -- economics
Ambulatory Care -- statistics & numerical data
Cardiovascular Agents -- economics
Cardiovascular Agents -- therapeutic use
Drug Utilization -- statistics & numerical data
Facilities and Services Utilization -- statistics & numerical data
Forecasting
Health Benefit Plans, Employee -- economics
Hospitalization -- economics
Hospitalization -- statistics & numerical data
Hypertension -- drug therapy
Middle Aged
Humans
United States

44. The rising cost of specialty drugs drove spending increases for people with multiple sclerosis

Author(s):
Johnson, Bill, author
Publication:
Washington, DC : Health Care Cost Institute, April 2018
Subject(s):
Drug Costs
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Multiple Sclerosis -- economics
Multiple Sclerosis -- drug therapy
Dihydroorotate Oxidase -- antagonists & inhibitors
Dimethyl Fumarate -- economics
Fingolimod Hydrochloride -- economics
Forecasting
Glatiramer Acetate -- economics
Interferon beta-1a -- economics
Interferon beta-1b -- economics
Humans
United States

45. Spending on individuals with type 1 diabetes and the role of rapidly increasing insulin prices

Author(s):
Biniek, Jean Fugleston, author
Johnson, William, author
Publication:
Washington, DC : Health Care Cost Institute, January 2019
Subject(s):
Diabetes Mellitus, Type 1 -- drug therapy
Diabetes Mellitus, Type 1 -- economics
Health Expenditures -- statistics & numerical data
Health Expenditures -- trends
Insulin -- economics
Insulin -- therapeutic use
Drug Costs -- trends
Forecasting
Insulins -- economics
Insulins -- therapeutic use
Humans
United States

46. Population aging, entitlement growth, and the economy

Publication:
Washington, D.C. : AARP Public Policy Institute, c2007
Subject(s):
Demography
Economics -- trends
Medicaid -- economics
Medicare -- economics
Social Security -- economics
Age Distribution
Disabled Persons -- statistics & numerical data
Forecasting
Health Expenditures -- trends
Income
Insurance Coverage -- economics
Insurance Coverage -- trends
Insurance, Health -- economics
Insurance, Health -- trends
Poverty
Medicaid -- trends
Medicare -- trends
Retirement -- economics
Retirement -- trends
Social Security -- trends
Humans
United States

48. Rx Watchdog report: comparative measures of price change for prescription drugs and other goods

Publication:
Washington, D.C. : AARP Public Policy Institute, c2009
Subject(s):
Drug Costs -- statistics & numerical data
Health Expenditures -- statistics & numerical data
Medicare Part D -- economics
Prescription Drugs -- economics
Drug Costs -- trends
Drugs, Generic -- economics
Forecasting
Health Expenditures -- trends
Inflation, Economic
Humans
United States